Please login to the form below

Not currently logged in
Email:
Password:

Unified Patent Court

This page shows the latest Unified Patent Court news and features for those working in and with pharma, biotech and healthcare.

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

As the European Patent Organisation (“EPO”) is independent of the EU, protection for European patents granted in the UK will continue to be available through the EPO post-Brexit, even in ... Developments in relation to the Unified Patent Court

Latest news

  • Innovation and the pharma patent court Innovation and the pharma patent court

    As the UK prepares to exit the European Union a unified patent system is still essential. ... However, participation in the UPC system includes accepting that the judgments of the European courts will prevail over judgments of the UK courts, even if the

  • Brexit: Bad for health, science and pharma Brexit: Bad for health, science and pharma

    A Leave vote would consequently seem to make it untenable for the EMA - which employs 885 people in the UK - as well as the soon-to-be-launched Unified Patent Court ... Its position is that EU membership offers the UK ‘various advantages’, pointing

  • UK biopharma says Brexit would be UK biopharma says Brexit would be "bad for business"

    It has been suggested that in the event of Brexit the EMA and the soon-to-be-launched Unified Patent Court would be relocated from London, according to a report in

  • Opt in or opt out? Opt in or opt out?

    The Unitary Patent (UP) and Unified Patent Court (UPC) will fundamentally change the way patents are granted and enforced in Europe. ... There are many other aspects of the Unified Patent package that may influence the future thinking of life sciences

  • Politically acceptable - a unified patent for Europe Politically acceptable - a unified patent for Europe

    But will Europe’s Unified Patent Court help or harm the pharma sector? ... The Unified Patent Court (UPC) is the result of an agreement between 27 European countries to create a single patent for Europe (the 'Unitary Patent'), with a single court (the

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    Without a withdrawal agreement, the UK’s participation in the European Patent and the Unified Patent Court, whose division dealing with life science cases is due to be housed in London,

  • Brexit: Implications for the pharma industry Brexit: Implications for the pharma industry

    Patents. In November 2016, the UK Government announced it would proceed with plans to ratify the Unitary Patent and Unified Patent Court (UPC) regime, with the UPC likely to operate from ... The current European Patent system will be unaffected by Brexit

  • Deal Watch June 2016 Deal Watch June 2016

    It is most likely that the Unitary Patent system and Unified Patent Court (UPC) Agreement will be delayed for years (Unitary Patents are intended to provide a cost-effective means of ... pan-EU patent protection without the need to validate each patent

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics